The COVID-19 pandemic saw major spikes in interest around biotech ventures crafting alternative proteins, startups producing plant-based foods, and everything in between–including B2B supply chain and ingredient companies.
Today, doomsday headlines are asserting that food tech’s big wave is over. But is it? And what fueled venture capital’s interest in taking on and investing in global challenges like food security, anyway?
